Empirical Validation of the NOAH6 Hierarchical Regulatory Model: Retrospective Analysis of 14 Real-World Studies

Abstract The NOAH6 model conceptualizes carcinogenesis as a systems-level failure arising from collapse of hierarchical regulation across five interacting layers: neural–perceptual regulation (R1), autonomicstress signaling (R2), endocrine regulation (R3), stromal–immune–microenvironmental regulation (R4), and cellular proliferative and phenotypic output (R5). Within this framework, durable disease control is predicted to require coordinated regulation across multiple layers, whereas isolated intervention at any single layer is expected to produce intrinsically unstable outcomes. In this work, a structured retrospective analysis of 14 independent, publicly published preclinical and clinical studies is performed to test this qualitative systems-level prediction. Each analyzed study selectively targeted a single regulatory layer—or a narrow subset of mechanisms within one layer—while reporting downstream biological and/or clinical outcomes. The studies span diverse disease contexts and intervention types, including stromal and immune modulation in pancreatic ductal adenocarcinoma, autonomic and endocrine interventions in solid tumors, and neural and psychological stress–inflammation paradigms. Across all 14 studies, a highly consistent outcome pattern is observed. Isolated targeting of an individual regulatory layer invariably produces measurable biological effects, such as tumor microenvironment remodeling, immune or stromal modulation, biomarker shifts, transient clinical responses, or demonstrated upstream–downstream causal coupling. However, no study achieves stable systemic control, as reflected by durable progression-free survival (PFS), overall survival (OS), or long-term disease stabilization. Instead, outcomes are characterized by reversibility, compensatory pathway activation, paradoxical acceleration, or treatment-limiting toxicity. Importantly, the analyzed studies provide direct empirical evidence that higher regulatory layers exert directional control over lower layers (e.g., R1–R3 → R4/R5, and R4 → R5), while simultaneously demonstrating that such control, when applied in isolation, is insufficient to lock the system into a stable controlled state. This convergence of transient efficacy, negative phase III outcomes, and reproducible upstreamdownstream coupling across independent studies supports a central qualitative prediction of the NOAH6 model: each regulatory layer is functionally active and modulable, yet no single layer is sufficient for durable disease control when targeted alone. These findings do not constitute quantitative therapeutic validation of NOAH6, nor do they propose specific treatment regimens. Rather, they provide structural empirical support for hierarchical conditionality in carcinogenesis and disease persistence, suggesting that future therapeutic strategies must explicitly address multi-layer regulatory coordination rather than increasingly precise but isolated single-layer interventions.